MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)

Alector, Inc. (ALEC)

Alector, Inc. (ALEC)

||
||

Balance Sheets Overview

Current Ratio
526.02%
Quick Ratio
526.02%
Cash Ratio
175.01%
Debt to Asset Ratio
104.91%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Deferred revenue, long-term port...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
59,915
76,962
65,802
76,503
Marketable securities
112,883
129,553
190,222
214,605
Prepaid expenses and other current assets
7,289
8,569
10,428
9,277
Total current assets
180,087
215,084
266,452
300,385
Property and equipment, gross
-
-
48,334
-
Less accumulated depreciation and amortization
-
-
37,493
-
Property and equipment, net
8,912
9,934
10,841
12,714
Operating lease right-of-use assets
11,657
12,683
13,712
15,869
Restricted cash
1,846
1,846
1,846
1,846
Other assets
353
369
386
4,471
Total assets
202,855
239,916
293,237
335,285
Accounts payable
2,283
1,423
1,691
4,757
Accrued clinical supply costs
2,141
1,044
3,669
3,547
Accrued liabilities
7,036
10,931
19,299
18,332
Deferred revenue, current portion
0
6,723
6,684
11,743
Payable to collaboration partner
3,717
10,229
17,289
10,788
Refund liability to collaboration partner, current portion
0
0
11,449
21,818
Operating lease liabilities, current portion
9,211
9,135
9,056
8,979
Short-term debt
-
1,480
366
-
Debt, current portion
9,848
-
-
-
Total current liabilities
34,236
40,965
69,503
79,964
Deferred revenue, long-term portion
162,866
162,866
164,537
167,269
Debt, long-term portion
0
8,287
9,323
9,611
Refund liability to collaboration partner, long-term portion
-
-
0
0
Operating lease liabilities, long-term portion
13,699
15,646
17,488
19,285
Other long-term liabilities
2,024
1,770
1,737
1,444
Total liabilities
212,825
229,534
262,588
277,573
Common stock, 0.0001 par value 200,000,000 shares authorized 111,656,805 and 110,362,581 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
11
11
11
10
Additional paid-in capital
1,008,121
1,005,461
1,002,528
992,294
Accumulated other comprehensive income (loss)
-126
-104
166
197
Accumulated deficit
-1,017,976
-994,986
-972,056
-934,789
Total stockholders' equity (deficit)
-9,970
10,382
30,649
57,712
Total liabilities and stockholders' equity (deficit)
202,855
239,916
293,237
335,285
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

ALEC Balance Sheet Sankey DiagramSankey diagram visualizing ALEC balance sheet for the periodMarketable securities$112,883K (-57.00%↓ Y/Y)Cash and cashequivalents$59,915K (33.83%↑ Y/Y)Prepaid expenses andother current assets$7,289K (-38.74%↓ Y/Y)Total current assets$180,087K (-43.58%↓ Y/Y)Operating leaseright-of-use assets$11,657K (-31.39%↓ Y/Y)Property and equipment,net$8,912K (-35.95%↓ Y/Y)Restricted cash$1,846K (0.00%↑ Y/Y)Other assets$353K (-92.15%↓ Y/Y)Total assets$202,855K (-43.09%↓ Y/Y)Accumulated deficit-$1,017,976K (-13.09%↓ Y/Y)Accumulated othercomprehensive income (loss)-$126K (-231.25%↓ Y/Y)Total liabilities andstockholders' equity...$202,855K (-43.09%↓ Y/Y)Total stockholders'equity (deficit)-$9,970K (-114.01%↓ Y/Y)Additional paid-in capital$1,008,121K (3.80%↑ Y/Y)Common stock, 0.0001par value...$11K (22.22%↑ Y/Y)Total liabilities$212,825K (-25.39%↓ Y/Y)Deferred revenue,long-term portion$162,866K (-3.56%↓ Y/Y)Total currentliabilities$34,236K (-59.41%↓ Y/Y)Operating leaseliabilities, long-term...$13,699K (-34.90%↓ Y/Y)Other long-termliabilities$2,024K (40.17%↑ Y/Y)Debt, current portion$9,848K Operating leaseliabilities, current portion$9,211K (3.45%↑ Y/Y)Accrued liabilities$7,036K (-50.50%↓ Y/Y)Payable tocollaboration partner$3,717K (-43.74%↓ Y/Y)Accounts payable$2,283K (2.98%↑ Y/Y)Accrued clinical supplycosts$2,141K (-58.43%↓ Y/Y)